(Q33188860)

23 July 2017

title

The course of neuropathy after cessation of cisplatin treatment, combined with Org 2766 or placebo (English)

1 reference

23 July 2017

0 references

1 reference

1 reference

4 December 2023

author name string

A. Hovestadt

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1315383

12 September 2022

M. E. van der Burg

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1315383

12 September 2022

H. B. Verbiest

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1315383

12 September 2022

W. L. van Putten

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1315383

12 September 2022

C. J. Vecht

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1315383

12 September 2022

language of work or name

1 reference

1 March 1992

1 reference

full work available at URL

23 July 2017

https://repub.eur.nl/pub/76642/REPUB_76642.pdf

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1315383

http://link.springer.com/content/pdf/10.1007/BF00833914.pdf

4 December 2023

file format

Portable Document Format

1 reference

http://link.springer.com/article/10.1007/BF00833914/fulltext.html

4 December 2023

1 reference

http://link.springer.com/content/pdf/10.1007/BF00833914

4 December 2023

1 reference

4 December 2023

1 reference

23 July 2017

volume

239

1 reference

23 July 2017

issue

3

1 reference

23 July 2017

page(s)

143-146

1 reference

Prevention of cisplatin neurotoxicity with an ACTH(4-9) analogue in patients with ovarian cancer

23 July 2017

cites work

1 reference

12 December 2020

Efficacy of the neuropeptide ORG.2766 in the prevention and treatment of cisplatin-induced neurotoxicity in rats.

1 reference

12 December 2020

Incidence of neuropathy in 395 patients with ovarian cancer treated with or without cisplatin

1 reference

12 December 2020

Evidence that the neurotrophic actions of alpha-MSH may derive from its ability to mimick the actions of a peptide formed in degenerating nerve stumps

1 reference

12 December 2020

Vibration perception and thermoperception as quantitative measurements in the monitoring of cisplatin induced neurotoxicity

1 reference

12 December 2020

Cisplatin neuropathy. Clinical, electrophysiologic, morphologic, and toxicologic studies

1 reference

12 December 2020

Polyneuropathy induced by cisplatin

1 reference

12 December 2020

Cisplatin-induced peripheral neuropathy. Frequent off-therapy deterioration, demyelinating syndromes, and muscle cramps

1 reference

12 December 2020

Electrophysiological study of the peripheral and central neurotoxic effect of cis-platin

1 reference

12 December 2020

Peripheral sensory neuropathy and cisplatin chemotherapy

1 reference

12 December 2020

Standardised method of determining vibratory perception thresholds for diagnosis and screening in neurological investigation

1 reference

12 December 2020

Long-term neurotoxicity in patients treated with cisplatin, vinblastine, and bleomycin for metastatic germ cell cancer

1 reference

12 December 2020

Progressive paresthesias after cessation of therapy with very high-dose cisplatin

1 reference

12 December 2020

Unusual presentation of cis-platinum neuropathy

1 reference

12 December 2020

High-dose cisplatin administration without hypertonic saline: observation of disabling neurotoxicity

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00833914

1 reference

Dimensions Publication ID

23 July 2017

1033676507

0 references

1 reference